Emily Bergin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Emily Bergin

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Pharmacoepidemiology and Drug Safety|July 31, 2023

Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018Emily Bergin, Haley M Zylberberg, Benjamin Lebwohl, et al.

Journal of Health Economics and Outcomes Research|March 28, 2024

Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?Anne M Sydor, Emily Bergin, Jonathan Kay, et al.

Cancer|November 10, 2020

What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strataMarie-Anne Durand, Renata W Yen, A James O'Malley, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Pharmacoepidemiology and Drug Safety|July 31, 2023

Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018Emily Bergin, Haley M Zylberberg, Benjamin Lebwohl, et al.

Journal of Health Economics and Outcomes Research|March 28, 2024

Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?Anne M Sydor, Emily Bergin, Jonathan Kay, et al.

Cancer|November 10, 2020

What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strataMarie-Anne Durand, Renata W Yen, A James O'Malley, et al.

Pageof 1